GGrantIndex
← Leaderboards

Mehboob A Hussain

Columbia University Health Sciences

$12,670,960
Attributed
$17,358,429
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.9M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,243,929 · 15

By mechanism

R01$12,239,270 · 8
P30$5,559,265 · 4
RC4$2,524,394 · 1
R24$492,000 · 1
R21$429,000 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusMouse ModelGlucoseInsulinCellsIn VivoSignal TransductionMediatingPancreasInsulin ResistanceCyclic AmpProteinsResponseCell PhysiologyInsulin SecretionBeta CellIsletObesityGenetic TranscriptionRegulationSignal PathwayHepatocyteIn VitroMolecular

Grant awards (48)

Differential Spatial cAMP Signaling in the Pancreatic Beta cell$705,817
R01 · FY2025 · DK · contact PI
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus$460,862
R01 · FY2025 · DK · contact PI
The Role of Kisspeptin in Metabolism Regulation$445,553
R01 · FY2025 · DK · contact PI
The Role of Kisspeptin in Metabolism Regulation$499,877
R01 · FY2024 · DK · contact PI
Pilot and Feasibility Program$479,665
P30 · FY2024 · DK · contact PI
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus$448,397
R01 · FY2024 · DK · contact PI
Expanded (Regional) Pilot and Feasibility Program$281,076
P30 · FY2024 · DK · contact PI
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus$483,542
R01 · FY2023 · DK · contact PI
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus$483,542
R01 · FY2022 · DK · contact PI
Glucagon signaling in metabolic homeostasis$307,092
R01 · FY2022 · DK · contact PI
In vivo Cell-Specific Exosome Analysis$234,000
R21 · FY2022 · AG · contact PI
Mechanism of Defective Incretin Action in Beta Cells during Type 2 Diabetes Mellitus$483,542
R01 · FY2021 · DK · contact PI
Glucagon signaling in metabolic homeostasis$307,092
R01 · FY2021 · DK · contact PI
In vivo Cell-Specific Exosome Analysis$195,000
R21 · FY2021 · AG · contact PI
Glucagon signaling in metabolic homeostasis$390,000
R01 · FY2020 · DK · contact PI
Hepatic endocrine suppression of the pancreatic beta-cell$365,094
R01 · FY2017 · DK · contact PI
CORE A: CELL BIOLOGY CORE$178,201
P30 · FY2017 · DK · contact PI
Hepatic endocrine suppression of the pancreatic beta-cell$127,918
R01 · FY2017 · DK · contact PI
JHU-UMD Diabetes Research Center$1,942,750
P30 · FY2016 · DK · contact PI
Hepatic endocrine suppression of the pancreatic beta-cell$509,091
R01 · FY2016 · DK · contact PI
CORE A: CELL BIOLOGY CORE$178,200
P30 · FY2016 · DK · contact PI
JHU-UMD Diabetes Research Center$1,942,750
P30 · FY2015 · DK · contact PI
Hepatic endocrine suppression of the pancreatic beta-cell$509,091
R01 · FY2015 · DK · contact PI
CORE A: CELL BIOLOGY CORE$178,200
P30 · FY2015 · DK · contact PI
Hepatic endocrine suppression of the pancreatic beta-cell$511,812
R01 · FY2014 · DK · contact PI
CORE A: CELL BIOLOGY CORE$160,380
P30 · FY2014 · DK · contact PI
Beta-cell Proliferation$376,495
R01 · FY2013 · DK · contact PI
CORE A: CELL BIOLOGY CORE$218,043
P30 · FY2013 · DK · contact PI
Beta-cell Proliferation$390,151
R01 · FY2012 · DK · contact PI
Beta-cell Proliferation$390,151
R01 · FY2011 · DK · contact PI
Control of hepatic and b-cell function by co-activators$340,161
R01 · FY2011 · DK
High-Throughput Screen For FDA Approved Drugs That Amplify Beta-Cell Mass In Vivo$2,524,394
RC4 · FY2010 · DK
Mechanisms of Glucose Toxicity$492,000
R24 · FY2010 · DK
Beta-cell Proliferation$459,853
R01 · FY2010 · DK · contact PI
Control of hepatic and b-cell function by co-activators$360,554
R01 · FY2010 · DK
Control of hepatic and b-cell function by co-activators$21,000
R01 · FY2010 · DK
Endocrine pancreatic cell regeneration from bone marrow$8,234
R01 · FY2010 · DK · contact PI
Beta-cell Proliferation$451,000
R01 · FY2009 · DK · contact PI
Control of hepatic and b-cell function by co-activators$390,474
R01 · FY2009 · DK
Endocrine pancreatic cell regeneration from bone marrow$30,096
R01 · FY2009 · DK · contact PI
Control of hepatic and b-cell function by co-activators$23,698
R01 · FY2009 · DK
Control of hepatic and b-cell function by co-activators$360,430
R01 · FY2008 · DK
Endocrine pancreatic cell regeneration from bone marrow$299,546
R01 · FY2008 · DK · contact PI
Endocrine pancreatic cell regeneration from bone marrow$305,660
R01 · FY2007 · DK · contact PI
Endocrine pancreatic cell regeneration from bone marrow$313,828
R01 · FY2006 · DK · contact PI
Endocrine pancreatic cell regeneration from bone marrow$244,717
R01 · FY2005 · DK
Endocrine pancreatic cell regeneration from bone marrow$44,544
R01 · FY2005 · DK
Endocrine pancreatic cell regeneration from bone marrow$390,356
R01 · FY2003 · DK